These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 33845131)

  • 41. Hippocampus development and function: role of epigenetic factors and implications for cognitive disease.
    Lagali PS; Corcoran CP; Picketts DJ
    Clin Genet; 2010 Oct; 78(4):321-33. PubMed ID: 20681996
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Toward development of epigenetic drugs for central nervous system disorders: Modulating neuroplasticity via H3K4 methylation.
    Ricq EL; Hooker JM; Haggarty SJ
    Psychiatry Clin Neurosci; 2016 Dec; 70(12):536-550. PubMed ID: 27485392
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [EPIGENETIC FACTORS OF NEUROBIOLOGIC CHANGES IN FETUSES OF PREGNANT WOMEN WITH NEUROPSYCHIATRIC DISORDERS].
    Varadinova M; Metodieva R; Boyadzhieva N
    Akush Ginekol (Sofiia); 2015; 54(7):21-6. PubMed ID: 27025104
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Brain function and chromatin plasticity.
    Dulac C
    Nature; 2010 Jun; 465(7299):728-35. PubMed ID: 20535202
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The emerging role of chromatin remodelers in neurodevelopmental disorders: a developmental perspective.
    Mossink B; Negwer M; Schubert D; Nadif Kasri N
    Cell Mol Life Sci; 2021 Mar; 78(6):2517-2563. PubMed ID: 33263776
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Epigenetics in the therapy of psychiatric disorders].
    Iannitelli A; Biondi M
    Riv Psichiatr; 2014; 49(1):1. PubMed ID: 24572577
    [No Abstract]   [Full Text] [Related]  

  • 47. Redox Components: Key Regulators of Epigenetic Modifications in Plants.
    R M SK; Wang Y; Zhang X; Cheng H; Sun L; He S; Hao F
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32093110
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Epigenetic inheritance of disease and disease risk.
    Bohacek J; Mansuy IM
    Neuropsychopharmacology; 2013 Jan; 38(1):220-36. PubMed ID: 22781843
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Persistent Chromatin Modifications Induced by High Fat Diet.
    Leung A; Trac C; Du J; Natarajan R; Schones DE
    J Biol Chem; 2016 May; 291(20):10446-55. PubMed ID: 27006400
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epigenome Editing in the Brain.
    Bashtrykov P; Jeltsch A
    Adv Exp Med Biol; 2017; 978():409-424. PubMed ID: 28523558
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rapid and reversible epigenome editing by endogenous chromatin regulators.
    Braun SMG; Kirkland JG; Chory EJ; Husmann D; Calarco JP; Crabtree GR
    Nat Commun; 2017 Sep; 8(1):560. PubMed ID: 28916764
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Significance of higher-order chromatin architecture for neuronal function and dysfunction.
    Wilczynski GM
    Neuropharmacology; 2014 May; 80():28-33. PubMed ID: 24456745
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chromatin and epigenetic regulation of pre-mRNA processing.
    Brown SJ; Stoilov P; Xing Y
    Hum Mol Genet; 2012 Oct; 21(R1):R90-6. PubMed ID: 22936691
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The chromatin remodeling enzyme Chd4 regulates genome architecture in the mouse brain.
    Goodman JV; Yamada T; Yang Y; Kong L; Wu DY; Zhao G; Gabel HW; Bonni A
    Nat Commun; 2020 Jul; 11(1):3419. PubMed ID: 32647123
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 'Enhancing' red cell fate through epigenetic mechanisms.
    Rossmann MP; Zon LI
    Curr Opin Hematol; 2021 May; 28(3):129-137. PubMed ID: 33741760
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Epigenetic gene regulation, chromatin structure, and force-induced chromatin remodelling in epidermal development and homeostasis.
    Miroshnikova YA; Cohen I; Ezhkova E; Wickström SA
    Curr Opin Genet Dev; 2019 Apr; 55():46-51. PubMed ID: 31112907
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The epigenetic bottleneck of neurodegenerative and psychiatric diseases.
    Sananbenesi F; Fischer A
    Biol Chem; 2009 Nov; 390(11):1145-53. PubMed ID: 19747081
    [TBL] [Abstract][Full Text] [Related]  

  • 58. O-GlcNAcylation and chromatin remodeling in mammals: an up-to-date overview.
    Leturcq M; Lefebvre T; Vercoutter-Edouart AS
    Biochem Soc Trans; 2017 Apr; 45(2):323-338. PubMed ID: 28408473
    [TBL] [Abstract][Full Text] [Related]  

  • 59. TP63 links chromatin remodeling and enhancer reprogramming to epidermal differentiation and squamous cell carcinoma development.
    Yi M; Tan Y; Wang L; Cai J; Li X; Zeng Z; Xiong W; Li G; Li X; Tan P; Xiang B
    Cell Mol Life Sci; 2020 Nov; 77(21):4325-4346. PubMed ID: 32447427
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The epigenetic landscape of mammary gland development and functional differentiation.
    Rijnkels M; Kabotyanski E; Montazer-Torbati MB; Hue Beauvais C; Vassetzky Y; Rosen JM; Devinoy E
    J Mammary Gland Biol Neoplasia; 2010 Mar; 15(1):85-100. PubMed ID: 20157770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.